Save
PB0482 Clinical and Genetic-Based Refinement of the Warfarin Dose
ISTH Academy, Faculty / Presenters, 407707
PB0483 Enoxaparin for the Long-Term Therapy of Venous Thromboembolism in Patients with Cancer and Renal Insufficiency. The RIETECAT-RI Study
ISTH Academy, Faculty / Presenters, 407708
PB0474 Anticoagulant Management and Outcomes in Non-Traumatic Intracranial Hemorrhage Complicated by Venous Thromboembolism
ISTH Academy, Faculty / Presenters, 407709
PB0485 Use of DOACs in the Management of Upper Extremity Deep Venous Thrombosis: A Systematic Review
ISTH Academy, Faculty / Presenters, 407710
PB0475 Empowering Patient Ambassadors to Champion Research Outcomes that are a Priority for People Who Have Lived Experience with Venous Thromboembolism (VTE)
ISTH Academy, Faculty / Presenters, 407711
PB0476 Pharmacogenomics of Novel Direct Oral Anticoagulants: Newly Identified Genetic Variants
ISTH Academy, Faculty / Presenters, 407712
PB0477 Safety and Efficacy of Direct Oral Anticoagulants in Patients with Chronic Thromboembolic Pulmonary Hypertension
ISTH Academy, Faculty / Presenters, 407713
PB0478 Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the MAC Project
ISTH Academy, Faculty / Presenters, 407714
PB0479 The ABC-Bleeding Score for Prediction of On-Treatment Clinically Relevant Bleeding in Patients with Unprovoked Venous Thromboembolism: Results from the Prospective PLATO-VTE Study
ISTH Academy, Faculty / Presenters, 407715
PB0480 Tinzaparin Safety in Patients with Severe Renal Impairment
ISTH Academy, Faculty / Presenters, 407716
PB0467 Antithrombin Levels after Acute Pulmonary Embolism: The Thromboembolism Heparinization and Antithrombin Observational Study (THANOS-1)
ISTH Academy, Faculty / Presenters, 407717
PB0468 Direct Oral Anticoagulant Therapy in Adolescent Venous Thromboembolism: A Systematic Review
ISTH Academy, Faculty / Presenters, 407718
PB0469 Frequency of INR Monitoring and Their Impact on INR Control during the COVID-19 Pandemic
ISTH Academy, Faculty / Presenters, 407719
PB0470 Platelet Spreading/Clot Contraction Phenotype Correlates with Venous Thrombosis Response in Integrin Signaling Mutant Mice
ISTH Academy, Faculty / Presenters, 407720
PB0471 Thrombelastography-Defined Duration of Hypercoagulability Following Primary Total Hip and Total Knee Arthroplasty
ISTH Academy, Faculty / Presenters, 407721
PB0472 Use of Andexanet Alfa and 4-factor Prothrombin Complex Concentrate for Reversal Therapy in Severe Hemorrhage: A Single-Centre Cohort Study
ISTH Academy, Faculty / Presenters, 407722
PB0473 VTE Outcomes in Patients Treated with Direct Oral Anticoagulants and Concurrent Antiepileptic Drugs: Data from the START2 and the RIETE
ISTH Academy, Faculty / Presenters, 407723
PB0460 Clinical Effectiveness and Safety of Edoxaban in Obese Patients - Results of the Prospective Dresden NOAC Registry (NCT01588119)
ISTH Academy, Faculty / Presenters, 407724
PB0461 Crucial Role of CX3CR1-CX3CL1 Axis in Thrombus Resolution in Murine DVT Model
ISTH Academy, Faculty / Presenters, 407725
PB0462 Early Discharge and Home Treatment of Patients with Acute Pulmonary Embolism in the Tertiary Care Setting
ISTH Academy, Faculty / Presenters, 407726
PB0463 Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project
ISTH Academy, Faculty / Presenters, 407727
PB0464 Smaller Nadroparin Dose Reductions Required for Patients with Renal Impairment: A Multicenter Study
ISTH Academy, Faculty / Presenters, 407728
PB0465 Trends in Anticoagulant Treatment Duration and Outcomes after Pulmonary Embolism between 2014 and 2019: A Nationwide Cohort Study
ISTH Academy, Faculty / Presenters, 407729
PB0458 Pharmacokinetic Analysis of Apixaban in Patients with End Stage Renal Disease Undergoing Dialysis, Real World Data from a Tertiary Centre in London, UK – A Retrospective Audit
ISTH Academy, Faculty / Presenters, 407730
PB0459 The Impact of Gastrointestinal Surgeries on Peak Plasma Anti-Xa Direct Oral Anticoagulant Levels
ISTH Academy, Faculty / Presenters, 407731
PB0456 Predictors of Thrombus Resolution in Patients on Anticoagulation for a Thrombus in the Right Heart
ISTH Academy, Faculty / Presenters, 407732
PB1505 C-Reactive Protein Across the Menstrual Cycle in Females with Sickle Cell Disease
ISTH Academy, Faculty / Presenters, 407733
PB1504 Hormone Use and Cardiovascular Thromboembolic Risk among Transgender Women
ISTH Academy, Faculty / Presenters, 407734
PB1503 Significant Effect of Hormonal Contraception on Venous Thromboembolism Risk in Women with Sickle Cell Disease, but is Estrogen the Culprit?
ISTH Academy, Faculty / Presenters, 407735
PB1502 Hemostatic Imbalance Associated with Tamoxifen in Estrogen Receptor-Positive Breast Cancer Patients: An Observational Study
ISTH Academy, Faculty / Presenters, 407736
PB1545 Antiphospholipid Antibodies Profile in Women with Periodontal Disease
ISTH Academy, Faculty / Presenters, 407737
PB1546 Time is Everything: Case Report of an Acute Thrombosis of Mechanical Aortic Valve Prosthesis in a Pregnant Woman
ISTH Academy, Faculty / Presenters, 407738
PB1544 Bleeding Manifestations in Mothers with Hemophilia (Before Knowing Their Diagnosis): A Retrospective Analysis
ISTH Academy, Faculty / Presenters, 407739
PB1542 Venous Thromboembolism (VTE) in Pregnancy: Experience in One Public Hospital in Argentina
ISTH Academy, Faculty / Presenters, 407740
PB1541 Atypical Hemolytic Uremic Syndrome Associated with Post-Partum Hemorrhage: A Case Series and Systematic Review of Individual Participants Data
ISTH Academy, Faculty / Presenters, 407741
PB1537 Changes in Whole Blood Platelet Aggregation and Clotting Parameters during Pregnancy and Postpartum in Women with and without Heterozygous Factor V Leiden Mutation
ISTH Academy, Faculty / Presenters, 407742
PB1538 Pregnancy Outcomes in Women with Sickle Cell Trait
ISTH Academy, Faculty / Presenters, 407743
PB1539 The Influence of G169IA Mutation in the Factor V Gene (Leiden)
ISTH Academy, Faculty / Presenters, 407744
PB1534 A Detailed Phenomenological Study on General Health of Iranian Mothers with Severe Hemophiliac Children Regarding to Applied Parenting Styles and Perceived Family Interactions
ISTH Academy, Faculty / Presenters, 407745
PB1535 Dynamics of Hemostasis in Women Undergoing In Vitro Fertilization
ISTH Academy, Faculty / Presenters, 407746
PB1536 Plasmin Generation and Its Determinants in the Third Trimester of Normal Pregnancy
ISTH Academy, Faculty / Presenters, 407747
PB1532 How Can We Improve Recruitment to Trials for Prevention of Venous Thromboembolism during Pregnancy and the Puerperium? A Qualitative Evaluation of the Patients' Perspective
ISTH Academy, Faculty / Presenters, 407748
PB1531 Management and Outcomes of Pregnancy and Childbirth in Known and Unknown Haemophilia Carriers: A Retrospective Analysis from a Reference Center in Italy
ISTH Academy, Faculty / Presenters, 407749
PB1529 Anticoagulation Protocol of Therapeutic Unfractionated Heparin Administration for Pregnant Women with Mechanical Prosthetic Heart Valves
ISTH Academy, Faculty / Presenters, 407750
PB1530 Diagnostic Strategies in Postpartum Individuals with Suspected Venous Thromboembolism: A Scoping Review
ISTH Academy, Faculty / Presenters, 407751
PB1528 Understanding Patients' Perspectives and Barriers to Postpartum Clinical Trial Participation: A Qualitative Substudy of the Pilot PARTUM Trial
ISTH Academy, Faculty / Presenters, 407752
PB1527 Sticky Platelet Syndrome and Pregnancy Complications - 18 Years' Experience in National Center of Hemostasis and Thrombosis in Slovak Republic
ISTH Academy, Faculty / Presenters, 407753
PB1525 Healthcare Resource Utilization in Pregnant Women with Suspected Antithrombin Deficiency: Results from a Nationwide Hospital Chargemaster Database
ISTH Academy, Faculty / Presenters, 407754
PB1526 Impact of Maternal Cannabis Use on Fetal Vascularized Tissue Development
ISTH Academy, Faculty / Presenters, 407755
PB1519 Analysis of Aggregation Patterns Changes in Pregnant Women with Severe Preeclampsia
ISTH Academy, Faculty / Presenters, 407756
PB1520 Deep Learning Extracts Embedded Signatures Associated with Pregnancy and Preeclampsia from Circulating Vesicle Profiles
ISTH Academy, Faculty / Presenters, 407757
PB1521 Evaluating Haemostatic Changes during Pregnancy with Global Coagulation Assays - A Prospective Observation Study
ISTH Academy, Faculty / Presenters, 407758
PB1522 Facility Variation in Patients Qualifying for Venous Thromboembolism Prophylaxis after Cesarean Delivery in the United States hospitals were more likely to meet criteria when compared to other hospital types (Figure 2; p < 0.001 for all comparisons).
ISTH Academy, Faculty / Presenters, 407759
PB1523 Inter-Expert Algorithms Agreement to Diagnose Thrombotic Microangiopathies in Pregnancy
ISTH Academy, Faculty / Presenters, 407760
PB1524 Preferences of Pregnant Women for Postpartum Thromboprophylaxis: The Bicentric PREFER-PP Study
ISTH Academy, Faculty / Presenters, 407761
PB1516 CT-001, a Novel Factor VIIa, Demonstrates Enhanced In Vitro Procoagulant Activity in Peripartum Patient Samples
ISTH Academy, Faculty / Presenters, 407762
PB1517 Effect of Uteroplacental Manipulation on Hemostatic Markers during Cesarean Delivery and Hysterectomy for Placenta Accreta Spectrum
ISTH Academy, Faculty / Presenters, 407763
PB1514 Pre-Delivery Thrombin Generation in Women with Non-Severe Post-Partum Hemorrhage - A Nested Case-Control Study
ISTH Academy, Faculty / Presenters, 407764
PB1512 Antithrombin Concentrate Supplementation and Incidence of Coagulation Events in Pregnant Women Tested for Antithrombin Levels: Results from a Real-World Electronic Health Record (EHR) Database
ISTH Academy, Faculty / Presenters, 407765
PB1513 Post-Partum Hemorrhage and Maternal Death in Mozambique - An Autopsy Study
ISTH Academy, Faculty / Presenters, 407766
PB1509 Antiphosphatidylserine/Prothrombin Antibodies in Obstetric Antiphospholipid Syndrome: A Case-Control Study
ISTH Academy, Faculty / Presenters, 407767
PB1510 Circulating Extracellular Vesicles and Neutrophil Extracellular Traps Contribute to Endothelial Dysfunction in Pregnant Women with Preeclampsia
ISTH Academy, Faculty / Presenters, 407768
PB1511 Systematic Review on Hemostatic Biomarkers Predictive for Postpartum Hemorrhage
ISTH Academy, Faculty / Presenters, 407769
PB1508 Massive Platelet-Rich Thrombus Formation in Small Pulmonary Vessels in Amniotic Fluid Embolism
ISTH Academy, Faculty / Presenters, 407770
PO01 My Song Project: Music as a Patient Education and Motivation Strategy to Improve Adherence to Medication and Lifestyle Modifications
ISTH Academy, Faculty / Presenters, 407771
PO07 Is Covid-19 a Trigger Factor for Thrombotic Complications in Late Pregnancy?
ISTH Academy, Faculty / Presenters, 407772
PO05 Challenges with Warfarin Management in COVID-19 Patients
ISTH Academy, Faculty / Presenters, 407773
PO06 Blood Count Abnormalities in Coronavirus Infection 2019 (COVID-19)
ISTH Academy, Faculty / Presenters, 407774
PO04 SARS-CoV-2 Vaccinations and Risk of Venous Thrombosis - Case Control Study
ISTH Academy, Faculty / Presenters, 407775
PO12 Acquired Hemophilia A: Case Series
ISTH Academy, Faculty / Presenters, 407776
PO19 Clinical Experiences in Managing the Transition to rIX-FP: Switching, Surgical Management and On-Demand
ISTH Academy, Faculty / Presenters, 407777
PO18 Successful Long-Term Tolerance in Patients with Hemophilia A and Inhibitors Receiving Emicizumab Prophylaxis: A Single Saudi Center Experience
ISTH Academy, Faculty / Presenters, 407778
PO16 Hemorrhagic Complications in Patients with Hemophilia A
ISTH Academy, Faculty / Presenters, 407779
PO17 Impact of Bleeding Complications and Joint Disease on Quality of Life of Patients with Severe Haemophilia A: A Case Study of Kenyatta National Hospital Haemophilia Clinic
ISTH Academy, Faculty / Presenters, 407780
PO13 Complex Management a PWH and Guillain Barre Syndrome - Diagnostic and Treatment Challenges
ISTH Academy, Faculty / Presenters, 407781
PO15 Real-World Experience with Emicizumab Prophylaxis in 2 Portuguese Centers: Are These 4 Boys the First of Many?
ISTH Academy, Faculty / Presenters, 407782
PO11 Impact of Simoctocog Alfa Prophylaxis on Bleeding and Joint Health in Spanish Patients with Severe Haemophilia A
ISTH Academy, Faculty / Presenters, 407783
PO10 Nuwiq Dosing and Outcomes in the Management of Women/Girls with Haemophilia A Needing FVIII Treatment for Surgery - An International, Open-Label, Non-Controlled Study (NuDIMENSION)
ISTH Academy, Faculty / Presenters, 407784
PO14 Normalised Bleeds under Surgical Intervention and Less Hospital Frequencies, an Emicizumab Patient Case Experience in Western Kenya
ISTH Academy, Faculty / Presenters, 407785
PO08 Factor XIII Deficiency as Underlying Cause of Unexplained Intracranial Hemorrhage
ISTH Academy, Faculty / Presenters, 407786
PO09 Hemorrhagic Phenotype Associated with Non-Severe Deficit of Factor VII. Experience of a Single Center
ISTH Academy, Faculty / Presenters, 407787
PO23 Recurrent Thrombosis, Myocardial Infarction in a Patient with Antiphospholipid Syndrome; A Case Report
ISTH Academy, Faculty / Presenters, 407788
PO22 Thrombosis during Takayasu: An Unusual Clinical Presentation
ISTH Academy, Faculty / Presenters, 407789
PO27 Experience with Fostamatinib in a Single Center
ISTH Academy, Faculty / Presenters, 407790
PO24 Inmune Thrombocytopenia after Bone Marrow Transplantation: Experience and Management in a Spanish Center
ISTH Academy, Faculty / Presenters, 407791
PO26 Pulmonary Embolism in a Case with Thrombotic Thrombocytopenic Purpura after Plasmapheresis
ISTH Academy, Faculty / Presenters, 407792
PO25 MYH9 Related Disorder: A Benign R1933* MYH9 Mutation with Nephrology
ISTH Academy, Faculty / Presenters, 407793
PO49 Edoxaban in Cancer-Associated Thrombosis and Brain Metastases: The New Clinical Challenge for Direct Oral Anticoagulants. An Unusual Clinical Case
ISTH Academy, Faculty / Presenters, 407794
PO50 Genomic Analysis of RAS (NRAS, KRAS, HRAS) Gene (Codon 12, 13 and 61) and Risk of Deep Vein Thrombosis (DVT) in Patients with Metastatic Follicular Thyroid Cancer (FTC)
ISTH Academy, Faculty / Presenters, 407795
PO30 GastroIntestiNal Toxicities Induced by Anticancer Drugs (GINA) Used Lung Cancer
ISTH Academy, Faculty / Presenters, 407796
PO42 Thrombocytopenia Induced by Anticancer Agents (TIANA) in Lung Cancer
ISTH Academy, Faculty / Presenters, 407797
PO45 Risk Factors for Treatment Failure in Cancer-Associated Thrombosis: The MUHC Experience
ISTH Academy, Faculty / Presenters, 407798
PO31 Genetic Thrombophilia: Experience in a Single Center
ISTH Academy, Faculty / Presenters, 407799
PO33 Risk Factors for Venous Thromboembolic Complication on Patient with Glial Brain Tumor
ISTH Academy, Faculty / Presenters, 407800
PO32 Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Promoter Polymorphism and Other Thrombophilia in Patients with Acute Pulmonary Embolism: A Case-Control Study
ISTH Academy, Faculty / Presenters, 407801
PO46 Thrombophilia Workup in Adult Patients with Unprovoked Venous Thrombosis and Their Clinical Outcome
ISTH Academy, Faculty / Presenters, 407802
PO39 High-Risk Hereditary Thrombophilia as Trigger of Vascular Events According the Date of Regional Center of Antithrombotic Therapy
ISTH Academy, Faculty / Presenters, 407803
PO35 Venous Thrombo-Embolic Disease and Constitutional Thrombophilia
ISTH Academy, Faculty / Presenters, 407804
PO48 Deep Vein Thrombosis in the Elderly
ISTH Academy, Faculty / Presenters, 407805
PO51 Venous Thromboembolic Disease Revealing Tuberculosis: About 5 Cases
ISTH Academy, Faculty / Presenters, 407806

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings